Skip to main content
. 2013 Feb 8;6(3):710–720. doi: 10.1242/dmm.011445

Fig. 2.

Fig. 2.

Tamoxifen-induced PTEN deletion causes rapid and reproducible development of endometrial hyperplasia and in situ adenocarcinoma of the endometrium. (A–D) Comparison of histopathology and PTEN expression of Cre-ERT+/−PTENfl/fl mice injected with tamoxifen (TAM) or corn oil (CON) at different time points. (A–C) Representative images showing PTEN immunohistochemistry (bottom panels) and H&E staining (top panels) of uterus from mice sacrificed in weeks 0–2 (A), weeks 3–5 (B) or weeks 6–8 (C) after tamoxifen injection. (D) Graph showing the percentages of endometrial lesions distributed by periods of time.